产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 |
CAS No. |
117091-64-2 |
|---|---|
中文名称 |
4-((5R,5aR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-二羟基-2-甲基六氢吡喃并[3,2-d][1,3]二氧杂环己烯-6-基)氧基)-6-氧代-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二氧杂环戊烯-5-基)-2,6-二甲氧基苯基二氢磷酸酯 |
英文名称 |
4-((5R,5aR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-6-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl)-2,6-dimethoxyphenyl dihydrogen phosphate |
别名 |
528XYJ8L1N | NCGC00185753-04 | Etopophos | NSC18854 | Etopophos Preservative Free | ETOPOSIDE PHOSPHATE | 4'-DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-O-(R)-ETHYLIDENE-.BETA.-D-GLUCOPYRANOSIDE), 4'-(DIHYDROGEN PHOSPHATE) | CHEBI:135867 | Eposin Etopophos Vepesid |
标准英文名 |
4-((5R,5aR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-6-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl)-2,6-dimethoxyphenyl dihydrogen phosphate |
MDL No. |
MFCD00270859 |
分子式 |
C29H33O16P |
分子量 |
668.15 |
精确分子量 |
668.15 |
SMILES |
O=C1[C@]2([H])[C@H](C3=CC(OC)=C(C(OC)=C3)OP(O)(O)=O)C4=CC(OCO5)=C5C=C4[C@H]([C@@]2([H])CO1)O[C@@H]6O[C@@]7([H])[C@](O[C@@H](OC7)C)([H])[C@@H]([C@H]6O)O |
标准SMILES |
C[C@H]1O[C@@H]2[C@@H](CO1)O[C@@H](O[C@H]1[C@H]3COC(=O)[C@@H]3[C@@H](C3=CC4OCOC=4C=C31)C1C=C(OC)C(OP(O)(O)=O)=C(C=1)OC)[C@H](O)[C@H]2O |
用途 |
Etopophos (etoposide phosphate) is used as an anticancer chemotherapeutic agent for the treatment of various malignancies, including leukemia, lymphoma, and solid tumors; it is specifically indicated in combination regimens for recurrent ovarian cancer and has shown promise in the treatment of advanced gastric cancer in elderly patients; in March 2020, the FDA approved durvalumab (Imfinzi) in combination with standard-of-care chemotherapy (etoposide plus carboplatin or cisplatin) for first-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC). |
InChIKey |
LIQODXNTTZAGID-OCBXBXKTSA-N |
|
|
评论 |
|---|